Previous 10 | Next 10 |
MannKind Corp (MNKD) Q2 2022 Earnings Conference Call August 09, 2022, 17:00 ET Company Participants Michael Castagna - CEO & Director Steven Binder - CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Thomas Smith - SVB...
The following slide deck was published by MannKind Corporation in conjunction with their 2022 Q2 earnings call. For further details see: MannKind Corporation 2022 Q2 - Results - Earnings Call Presentation
Although MannKind's ( NASDAQ: MNKD ) Q2 2022 net loss narrowed 18% to $29M compared to the prior-year period, that wasn't enough to beat consensus estimates on the bottom line . Revenue of ~$18.9M, around a 19% year-over-year decline, however, was a beat. Mann...
MannKind press release ( NASDAQ: MNKD ): Q2 GAAP EPS of -$0.11 misses by $0.02 . Revenue of $18.89M (-18.9% Y/Y) beats by $3.27M . Afrezza gross profit for the second quarter of 2022 was $7.3 million compared to $5.6 million in the same period of 2021, an incre...
Conference Call to Begin Today at 5:00 p.m. (ET) Tyvaso DPI™ approved by the FDA in May representing the second FDA-approved product using the Technosphere ® inhalation platform V-Go ® acquired May 31; $2.1 million Net Revenue...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will release its 2022 second quarter and year to date financial results and its management will host a conference call to discuss these results and corporate updates at 5:0...
Shares of MannKind Corporation (NASDAQ: MNKD) , a biotech company that specializes in finding therapies for endocrine and orphan lung diseases, rose 10.4% on Monday. The stock closed at $3.45 on Friday and opened at that price on Monday. A little after 11 a.m., the stock reached its...
Small-cap summer is here, and there are a wide array of penny stocks to buy right now. Last week we saw the epic rallies in HKD stock, TBLT, and many others, which helped wake up cheap stocks. Not only that but the low float penny stocks trend has reemerged in the stock market today. Wi...
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of innovative therapeutic products for patients with endocrine and orphan lung diseases, announced today that i...
I will share the pros and cons of the coming battle these two companies will face in gaining market share with their competing drug. I will identify who I think will be winning this battle. Key caveat for who I think will win will be shared. For further details see: ...
News, Short Squeeze, Breakout and More Instantly...
Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through Dece...
Steven B. Binder announces planned retirement and is appointed Executive Vice President, Special Projects, effective April 22, 2024, through December 31, 2024 Christopher Prentiss appointed Chief Financial Officer, effective April 22, 2024 DANBURY, Conn. and WESTLAKE VILLAGE, Ca...
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated ap...